THE AUSTRALIAN CONTEXT
In Australia's healthcare system, there is a division between primary care (including outpatient pharmaceutical reimbursement), which is funded by the Federal government, and hospital care (including inpatient drug costs) primarily operated by State and Territory governments. In Australia, around 70% of healthcare is provided by government-funded public hospitals, with private hospitals providing significant services, mostly in obstetric and elective surgery [1] .
Australia has had a long history of standardized national treatment guidelines, which allows for the implementation of policies nationally across all levels of healthcare, including primary care and hospitals. These are developed by Therapeutic Guidelines, an independent not-for-profit organization that engages clinicians to review and update the literature. National guidelines have been an effective tool when combined with broader regulatory policies [2] . The National Prescribing Service (NPS), a government-funded organization, has implemented quality use of medicines initiatives targeted at primary care professionals and consumers [3] . Australia also has a strong system of hospital accreditation standards analogous to the Joint Commission in the USA. Of the ten National Standards developed by the Australian Commission on Safety and Quality in  Healthcare,  one  standard  focuses  on   preventing  and  controlling  healthcare-associated infections (standard 3) and from 2013 onwards has included substandard 3.14, which is specific to AMS [4] . A recently drafted set of Clinical Care Standards has been developed providing recommendations for the quality use of antimicrobials [5] .
The Australian healthcare system also has a number of limitations that remain challenges for implementation of AMS. Australia is yet to widely implement an electronic medical record despite government interest in this area [6] . Although electronic medical records are widely used in primary care, a number of different commercial systems are used, which is a significant barrier to information exchange.
Electronic medical records and prescribing systems are not yet commonplace in Australian hospitals.
Surveillance for antimicrobial use and antibiotic resistance is piecemeal and relies on a patchwork of small systems. The Australian Group on Antimicrobial Resistance (AGAR) has performed centralized testing for selected organisms, but this system is also voluntary and based primarily on data from large hospitals, which may bias reported results [7] . Public health surveillance systems cover resistance in bacterial notifiable diseases including pneumococci, tuberculosis, enteric pathogens and Neisseria spp.
However, a number of recent developments have provided a high-level policy framework to coordinate the current patchwork of surveillance and policy. After many years in abeyance following the pioneering work of the Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR) [8] surveyed Australian hospitals had a restricted formulary for antimicrobial prescribing, but only 25% had a multidisciplinary AMS team [13] . By 2012, a Victorian survey found that formulary restriction, auditing and feedback to prescribers were implemented in a majority of public metropolitan hospitals, but were not in public regional hospitals or private hospitals [14] . A Queensland survey also found that formulary restrictions were the mainstay of AMS programs, with auditing and feedback to prescribers present in 76% of hospitals [15] . The incorporation of AMS into the National Accreditation Standards for Australian
Hospitals in 2013 has mandated the need for AMS and has been a driving factor for the implementation and expansion of AMS in Australia.
Models of AMS in Public Hospital Settings
The In the latter, the complex nature of patients and need for timely access to broad-spectrum antibiotics mitigates the effectiveness of pre-prescription models of AMS, such as formulary restriction.
In response to these limitations, AMS ward rounds performing prospective auditing with intervention and feedback for those units with a moderate burden of infection form a key focus of this program. This post-prescription model of AMS has resulted in a reduction in the volume of prescribing of several key classes of antimicrobial agents [16] . [5] .
Process Indicators
In-house, site-specific data are often kept by AMS teams, and currently there is no requirement to report this externally. While cost has been used to justify AMS programs, the marked reduction in purchasing costs of broad-spectrum antimicrobial agents within Australia as generic formulations have become available, suggests that this approach is unlikely to be as successful and that other process outcomes should be used for evaluation. Some processes monitored at Alfred Health include use of the electronic approval/alert system (see Fig. 1a ), the number of patients reviewed by an AMS team per month and the number of recommendations made by an AMS team per month (see Fig. 1b ). In addition, data are reviewed on hospital-wide antimicrobial utilization and changes in broad-spectrum antimicrobial use [16] .
Antimicrobial Use
Many hospitals contribute data on a voluntary basis on antimicrobial utilization to the National Antimicrobial Utilisation Surveillance
Program (NAUSP). These data are based on pharmacy dispensing and distribution data using the World Health Organization (WHO)-defined daily dose method [17] . Although they provide useful data on prescribing trends over time, the nature of the data source results in considerable month-to-month variation, reflects the total volume rather than the number of prescriptions and does not provide data on the appropriateness of use. In particular, benchmarking between hospitals is difficult because of variation in the patient case mix.
Point Prevalence Surveys
The National Antimicrobial Prescribing Survey (NAPS) is an annual point prevalence survey undertaken in November of each year to coincide with Antimicrobial Awareness Week [18] . This survey includes items to assess the appropriateness of antimicrobial prescription and compliance with guidelines (either national or local). It has been conducted by an increasing number of hospitals on a voluntary basis since 2011 [18] . In 2013, it identified this at 151 contributing hospitals (encompassing approximately 12,800 individual antimicrobial prescriptions). At these hospitals, 70.8% of antimicrobial prescriptions were considered to be appropriately prescribed, while 59.7% of prescriptions were classed as compliant with national or endorsed local guidelines [19] . 
AMS IN OTHER SETTINGS

Private Hospitals
Although around 30% of all inpatient hospital care in Australia occurs in the private hospital sector [1] , AMS in private hospitals has lagged behind that seen in public hospitals [14] . There are significant cultural and organizational differences for private hospitals when compared to the Australian public sector, which holds important implications for the model of AMS that is feasible in this setting.
Principally, private hospitals often view their role as facilitating and servicing medical specialists' practices. This is reflected in the relatively autonomous practices of specialists, the role of pharmacists in simply providing medication rather than taking an active role in medication management and the relative lack of hospital-wide policies and coordinators of AMS activities [22] . For example, infectious diseases physicians are typically solely responsible for their own patients, with no additional hospital-wide role such as in infection control or AMS. Likewise, clinical microbiologists (employed by outsourced pathology services) and pharmacists may be limited to a supply function and do not have jurisdiction to oversee AMS programs in private hospitals [22] .
There is, however, significant opportunity for the private sector to tailor potential solutions for successful AMS program implementation. Establishing an antimicrobial prescribing policy that makes specialists aware of their responsibilities for judicious antimicrobial use by ensuring the prescribing policy forms part of their renewal for accreditation to admit patients can send a powerful message from hospital executive.
Pharmacists have been shown to be important advocates of AMS [23] , and there is significant scope for them to lead post-prescription review and periodic auditing if given the mandate to do so. Due to their pivotal role in private hospitals, nursing staff will clearly need to be part of any AMS program in private hospitals but further work is required to provide both the awareness, training and authority to effect change [22] .
Primary Care
Pharmaceutical Benefits Scheme
Australia has a public subsidy for drugs through the national Pharmaceutical Benefits Scheme (PBS), and this has an important influence on antimicrobial prescribing in Australia. The effect of the PBS has best been demonstrated for fluoroquinolones, where a coordinated national policy has restricted indications for use in national treatment guidelines, the requirement for an 'authority' to be obtained to prescribe fluoroquinolones on the PBS (medical practitioners need to call a prescribing approval service to obtain approval to prescribe) and the banning of fluoroquinolone use in food-producing animals [2] . This policy has resulted in a low rate of fluoroquinolone use in Australia and a relatively low rate of resistance to this valuable class of antimicrobials [2] .
The Drug Utilisation Subcommittee of the Pharmaceutical Benefits Advisory Committee recently released a review of the use of antibiotics in primary care in Australia [24] . In 2013, they reported that 45% of the Australian population were supplied at least one antibiotic and that the overall utilization of antimicrobials in Australia (22.8 Defined Daily Doses (DDDs)/1000 person days) was higher than the Organisation for Economic Cooperation and Development average (21.1 DDDs/1000 person days) [24] . The three most commonly prescribed antimicrobial agents were amoxycillin, cephalexin and amoxycillin/clavulanate combinations [24] .
National Prescribing Service
The NPS is an independent, government-funded organization founded in 1998 to improve the quality use of medicines as a component of the National Medicines Policy [25] . Similarly, another Melbourne study found that 36% of RACF residents were colonized with methicillin-resistant Staphylococcus aureus (MRSA), VRE or MDR gram-negative bacilli [28] .
There is no ongoing surveillance of antimicrobial use in Australian RACFs, but one 4-year Melbourne study has shown that the majority of antimicrobial agents used were oral, narrow-spectrum agents such as cephalexin and trimethoprim [29] . However, it also highlighted that a significant proportion of prescribing appeared to occur in patients without obvious, documented clinical findings suggestive of infection and that none of the participating RACFs had antimicrobial restriction policies in place. Qualitative work has identified a number of barriers and enablers to AMS in this setting [30] . Workflow-related factors included the lack of on-site medical care, pharmacy support, nurse-driven infection management, institutional policies and guidelines, and external expertise and diagnostic facilities. A subsequent survey found that stakeholders were generally supportive of AMS interventions and potential strategies included nursing-based education, aged-care-specific antibiotic guidelines and regular antibiotic surveillance [31] .
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